Physician profile
Derrick Su
NPI 1740569789
$52,636.12
in general payments reported to CMS, 2019-2025
99 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,777 · 2020: $4,309 · 2021: $6,807 · 2022: $7,666 · 2023: $9,030 · 2024: $9,738 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25K · Long Term Medical Supply Or Device Loan: $2,147 · Consulting Fee: $2,020 · Education: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24,608.56 |
| Long Term Medical Supply Or Device Loan | $2,147.25 |
| Consulting Fee | $2,020.00 |
| Education | $301.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $5,566.71 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $4,946.99 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $3,511.61 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,587.02 | 2019-2025 | Calquence, Imfinzi, Enhertu |
| Incyte Corporation | $2,131.74 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Merck Sharp & Dohme LLC | $2,007.59 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Celgene Corporation | $1,998.87 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $1,866.55 | 2019-2025 | Opdivo, Opdualag |
| Pfizer INC. | $1,703.88 | 2019-2025 | |
| Janssen Biotech, INC. | $1,503.33 | 2020-2025 | Darzalex, Tecvayli, Imbruvica |
| Amgen INC. | $1,328.05 | 2019-2025 | Kyprolis, Blincyto, Lumakras |
| Lilly USA, LLC | $1,275.03 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Pharmacyclics LLC, An Abbvie Company | $1,180.20 | 2019-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $1,177.20 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Genentech USA, INC. | $1,153.41 | 2019-2025 | Tecentriq, Venclexta, Polivy |
Show all 99 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,109.98 | 2020-2025 | |
| Astellas Pharma US INC | $1,078.34 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Seagen INC. | $1,031.44 | 2019-2023 | Adcetris, Padcev, Tukysa |
| Glaxosmithkline, LLC. | $1,015.37 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Gilead Sciences, INC. | $927.95 | 2019-2025 | Trodelvy |
| Alexion Pharmaceuticals, INC. | $922.20 | 2019-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $902.35 | 2019-2025 | Libtayo |
| Exelixis INC. | $894.25 | 2019-2025 | Cabometyx |
| Array Biopharma INC | $781.23 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Daiichi Sankyo INC. | $689.21 | 2022-2025 | Enhertu, Datroway, Vanflyta |
| Karyopharm Therapeutics INC. | $673.54 | 2021-2025 | Xpovio |
| Genzyme Corporation | $509.25 | 2019-2025 | |
| Sobi, INC | $496.94 | 2021-2025 | Doptelet, Doptelet |
| Puma Biotechnology, INC. | $460.53 | 2021-2025 | Nerlynx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $415.75 | 2019-2025 | Gilotrif |
| Stemline Therapeutics INC. | $398.45 | 2019-2025 | Orserdu, Elzonris |
| Aveo Pharmaceuticals, INC. | $370.77 | 2021-2025 | Fotivda |
| Rigel Pharmaceuticals, INC. | $337.93 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Kite Pharma, INC. | $337.30 | 2020-2024 | Yescarta |
| Emd Serono, INC. | $336.43 | 2019-2025 | Bavencio |
| Jazz Pharmaceuticals INC. | $318.35 | 2019-2025 | Vyxeos |
| Caris Mpi, INC. | $249.16 | 2025 | Mi Cancer Seek |
| Ipsen Biopharmaceuticals, INC | $244.74 | 2019-2025 | Somatuline Depot, Onivyde |
| Blueprint Medicines Corporation | $202.62 | 2020-2025 | Ayvakit |
| Beone Medicines USA, INC. | $196.66 | 2025 | Brukinsa, Tevimbra |
| Adc Therapeutics America, INC. | $188.41 | 2025 | |
| Coherus Oncology, INC. | $184.53 | 2024-2025 | Loqtorzi |
| Genmab U.S., INC. | $164.89 | 2023-2025 | Epkinly |
| Pharmaessentia USA Corporation | $157.48 | 2024-2025 | Besremi |
| Pharmacosmos Therapeutics INC. | $137.84 | 2020-2025 | Monoferric |
| Recordati_rare_diseases_inc. | $134.36 | 2023-2025 | Enjaymo, Sylvant |
| Tersera Therapeutics LLC | $125.99 | 2022-2025 | Zoladex, Quzyttir |
| Beigene USA, INC. | $118.03 | 2022-2025 | Brukinsa, Tevimbra |
| Taiho Oncology, INC. | $117.65 | 2022-2025 | |
| Myovant Sciences INC. | $101.10 | 2022 | |
| Kyowa Kirin, INC. | $91.26 | 2020-2025 | Poteligeo |
| Morphosys, US INC. | $89.16 | 2023 | Monjuvi |
| Mirati Therapeutics, INC. | $87.22 | 2023-2024 | Krazati |
| Foundation Medicine, INC. | $82.67 | 2019-2023 | |
| Iovance Biotherapeutics, INC. | $82.27 | 2025 | Amtagvi |
| Sumitomo Pharma America, INC. | $81.54 | 2024-2025 | Orgovyx |
| Teva Pharmaceuticals USA, INC. | $80.67 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $79.90 | 2019-2025 | Pyrukynd |
| Clovis Oncology, INC. | $78.72 | 2019-2020 | |
| Octapharma USA, INC. | $74.30 | 2021-2023 | Panzyga |
| Ge Healthcare | $73.50 | 2021-2025 | |
| Cti Biopharma Corp. | $72.05 | 2022-2023 | Vonjo |
| Dendreon Pharmaceuticals LLC | $71.31 | 2020-2023 | Provenge |
| Sun Pharmaceutical Industries INC. | $70.93 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $69.99 | 2023 | |
| Servier Pharmaceuticals LLC | $65.23 | 2021-2025 | |
| Deciphera Pharmaceuticals INC. | $58.97 | 2023-2025 | Qinlock, Romvimza |
| Organon LLC | $58.31 | 2022 | |
| Alnylam Pharmaceuticals INC. | $53.90 | 2025 | Givlaari |
| Epizyme, INC. | $53.57 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $52.42 | 2023-2024 | Trelstar |
| Dova Pharmaceuticals | $51.16 | 2019-2020 | |
| Partner Therapeutics, INC. | $48.08 | 2019 | |
| Boston Scientific Corporation | $44.04 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Fennec Pharmaceuticals, INC. | $43.80 | 2024-2025 | Pedmark, Fyarro |
| Springworks Therapeutics, INC. | $41.77 | 2024 | Ogsiveo |
| Acrotech Biopharma INC. | $41.45 | 2022-2025 | Beleodaq |
| Macrogenics, INC. | $39.74 | 2022 | |
| Amag Pharmaceuticals, INC. | $38.85 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $37.61 | 2019 | |
| Spectrum Pharmaceuticals INC. | $32.56 | 2023-2024 | Rolvedon |
| Geron Corporation | $30.45 | 2025 | Rytelo |
| Tempus Ai, INC | $29.48 | 2024 | |
| Syndax Pharmaceuticals, INC. | $28.84 | 2025 | |
| Immunogen, INC. | $27.54 | 2023 | Elahere |
| Chiesi USA, INC. | $27.41 | 2020 | |
| Immunocore Limited | $27.11 | 2025 | Kimmtrak |
| Adaptive Biotechnologies Corporation | $26.69 | 2025 | Clonoseq |
| Amneal Pharmaceuticals LLC | $26.56 | 2023 | Avastin, Neupogen, Neulasta |
| Myriad Genetic Laboratories, INC. | $26.34 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $23.14 | 2023 | Firdapse |
| Emmaus Medical, INC. | $21.22 | 2024 | Endari |
| Mylan Institutional INC. | $21.06 | 2019 | |
| Progenics Pharmaceuticals, INC. | $19.16 | 2022 | |
| Tg Therapeutics, INC. | $18.80 | 2021 | |
| West Therapeutics Development, LLC | $18.29 | 2019 | |
| Immunomedics, INC. | $18.07 | 2020 | |
| Azurity Pharmaceuticals, INC. | $17.53 | 2025 | Danziten |
| Menarini Silicon Biosystems, INC. | $12.28 | 2025 | Cellsearch |
Drugs and devices associated with these payments
Lenvima $2,910Kisqali $2,513Imbruvica $1,055Keytruda $981Ultomiris $749Reblozyl $688Enhertu $679Jaypirca $660Epkinly $640Libtayo $634Darzalex $592Verzenio $586Nubeqa $545Calquence $538Xpovio $536Xtandi $527Monjuvi $526Imfinzi $493Jakafi $450Opdivo $429Lynparza $396Tukysa $387Tecvayli $384Cabometyx $377Mektovi $360Braftovi $360Retevmo $347Rybrevant $340Orserdu $337Ibrance $333Fruzaqla $324Ojjaara $322Opdualag $321Padcev $286Xofigo $279Venclexta $277Trodelvy $272Jemperli $269Tecentriq $266Talvey $262Mi Cancer Seek $249Pluvicto $245Pemazyre $237Fotivda $229Adcetris $212Orgovyx $207Elahere $206Pomalyst $205Sarclisa $195Elrexfio $194Doptelet $191Scemblix $191Welireg $191Lutathera $190Zynlonta $188Lorbrena $188Inlyta $182Alunbrig $172Fabhalta $172Brukinsa $166Tavalisse $159Rezlidhia $159Besremi $157Zejula $156Ayvakit $155Bosulif $153Vonjo $149Piqray $147Onivyde $145Somatuline Depot $145Xalkori $140Zynyz $137Erleada $136Vitrakvi $130Stivarga $130Vyloy $130Tevimbra $130Talzenna $129Monoferric $124Comirnaty $118Ninlaro $115Tivdak $109Mekinist $104Lonsurf $101Inqovi $101Zepzelca $98.63Udenyca $97.14Carvykti $93.34Datroway $89.76Nerlynx $89.01Elitek $88.19Loqtorzi $87.39Krazati $87.22Amtagvi $82.27Tagrisso $78.91Zoladex $71.28Enjaymo $71.06Paxlovid $71.05Poteligeo $70.87Synagis $64.71
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.